Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up

Neurology. 1989 Aug;39(8):1113-5. doi: 10.1212/wnl.39.8.1113.

Abstract

We studied the effects of carbamazepine (CBZ) (400 and 600 mg per day) in 10 patients with cerebellar tremors in a single-blind manner. All patients improved on a clinical rating scale and by accelerometric recording; there was no improvement with placebo. Our data suggest that CBZ may be a valuable drug in cerebellar tremors.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Carbamazepine / administration & dosage
  • Carbamazepine / therapeutic use*
  • Cerebellar Diseases / drug therapy*
  • Clinical Trials as Topic
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Time Factors
  • Tremor / drug therapy*

Substances

  • Carbamazepine